EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Overexpression of miR-199b-5p in Colony Forming Unit-Hill’s Colonies Positively Mediates the Inflammatory Response in Subclinical Cardiovascular Disease Model: Metformin Therapy Attenuates Its Expression

Sherin Bakhashab iD, Rosie Barber, Josie O'Neill, Catherine Arden iD, Jolanta U Weaver

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25158087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sherin Bakhashab und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, King Abdulaziz University, P.O. Box 80218, Jeddah 21589, Saudi Arabia. Hauptthemen laut MEDLINE: MicroRNAs, Metformin, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diabetes Research and Wellness Foundation, Diabetes Research Fund at Queen Elizabeth Hospital, UK, Diabetes Research and Wellness Foundation, UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Well-controlled type 1 diabetes (T1DM) is characterized by inflammation and endothelial dysfunction, thus constituting a suitable model of subclinical cardiovascular disease (CVD). miR-199b-5p overexpression in murine CVD has shown proatherosclerotic effects. We hypothesized that miR-199b-5p would be overexpressed in subclinical CVD yet downregulated following metformin therapy. Inflammatory and vascular markers were measured in 29 individuals with T1DM and 20 matched healthy controls (HCs). miR-199b-5p expression in CFU-Hill’s colonies was analyzed from each study group, and correlations with inflammatory/vascular health indices were evaluated. Significant upregulation of miR-199b-5p was observed in T1DM, which was significantly downregulated by metformin. miR-199b-5p correlated positively with vascular endothelial growth factor-D and c-reactive protein (CRP: nonsignificant). ROC analysis determined miR-199b-5p to define subclinical CVD by discriminating between HCs and T1DM individuals. ROC analyses of HbA1c and CRP showed that the upregulation of miR-199b-5p in T1DM individuals defined subclinical CVD at HbA1c > 44.25 mmol and CRP > 4.35 × 106 pg/mL. Ingenuity pathway analysis predicted miR-199b-5p to inhibit the target genes SIRT1, ETS1, and JAG1. Metformin was predicted to downregulate miR-199b-5p via NFATC2 and STAT3 and reverse its downstream effects. This study validated the antiangiogenic properties of miR-199b-5p and substantiated miR-199b-5p overexpression as a biomarker of subclinical CVD. The downregulation of miR-199b-5p by metformin confirmed its cardio-protective effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMetforminCardiovascular DiseasesHumansMaleFemaleAdultDiabetes Mellitus, Type 1InflammationSirtuin 1C-Reactive ProteinMiddle AgedGene Expression RegulationSTAT3 Transcription FactorHypoglycemic AgentsJagged-1 ProteinBiomarkersCase-Control Studies

Stichwörter der Autor:innen

CFU-Hill coloniesmetforminmiR-199b-5psubclinical CVD

Substanzen

MicroRNAsMetforminmirn199 microRNA, humanSirtuin 1C-Reactive ProteinSTAT3 Transcription FactorHypoglycemic AgentsJagged-1 ProteinBiomarkersJAG1 protein, human

Autor:innen und Institutionen

  • Biochemistry Department, King Abdulaziz University, P.O. Box 80218, Jeddah 21589, Saudi Arabia.
  • Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
  • Center of Excellence in Genomic Medicine Research, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia.
  • Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
  • Department of Diabetes, Queen Elizabeth Hospital, Gateshead, Newcastle upon Tyne NE9 6SH, UK.
  • Vascular Biology and Medicine Theme, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.

ORCID-Profile: Sherin Bakhashab, Catherine Arden

Förderung

  • Diabetes Research and Wellness Foundation
  • Diabetes Research Fund at Queen Elizabeth Hospital, UK
  • Diabetes Research and Wellness Foundation, UK
  • Diabetes Research Fund at Queen Elizabeth Hospital, Gateshead, UK

Zitieren

APA

Bakhashab, S., Barber, R., O'Neill, J., Arden, C., & Weaver, J. U. (2024). Overexpression of miR-199b-5p in Colony Forming Unit-Hill’s Colonies Positively Mediates the Inflammatory Response in Subclinical Cardiovascular Disease Model: Metformin Therapy Attenuates Its Expression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158087

Vancouver

Bakhashab S, Barber R, O'Neill J, Arden C, Weaver JU. Overexpression of miR-199b-5p in Colony Forming Unit-Hill’s Colonies Positively Mediates the Inflammatory Response in Subclinical Cardiovascular Disease Model: Metformin Therapy Attenuates Its Expression. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158087

BibTeX
@article{Bakhashab2024,
  author = {Bakhashab, Sherin and Barber, Rosie and O'Neill, Josie and Arden, Catherine and Weaver, Jolanta U},
  title = {Overexpression of miR-199b-5p in Colony Forming Unit-Hill’s Colonies Positively Mediates the Inflammatory Response in Subclinical Cardiovascular Disease Model: Metformin Therapy Attenuates Its Expression},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25158087}
}
Kostenlos starten →